Cécile L.
- Country
- France
- Department
- Cancérologie
Research Overview
- Phase II Evaluation of Vemurafenib Monotherapy in Patients with Metastatic or Unresectable Locally Advanced Malignancies Harboring BRAF Genomic Alterations
- Evaluation of Isatuximab, Pomalidomide, and Dexamethasone Efficacy in AL Amyloidosis Patients Lacking VGPR Post-Therapy
- Phase III Randomized Open-Label Multicenter Trial of Ruxolitinib vs. Hydroxycarbamide or Peginterferon Alfa-2a in High-Risk Polycythemia Vera Patients
Data & Insights
Has run more than one trial at 89 of 233 partner sites.
Specializations
Gastrointestinal Oncology
The investigator specializes in treating colorectal cancer, with particular emphasis on stage II and III colon carcinoma. Their work extends to advanced treatment approaches for pancreatic adenocarcinoma, exploring various therapeutic combinations.
- Colon Cancer Management
- Pancreatic Cancer Treatment
- Adjuvant Therapy Optimization
Their research includes evaluation of novel treatment strategies and circulating tumor DNA-based decision making in cancer care.
Hematologic Malignancies
The investigator focuses on treating complex blood disorders including diffuse large B-cell lymphoma, polycythemia vera, and AL amyloidosis. Their expertise encompasses innovative therapeutic combinations and treatment strategies.
- Lymphoma Treatment
- Myeloproliferative Disorders
- Amyloidosis Management
Their work involves evaluating novel antibody-drug combinations and targeted therapies for blood disorders.
Precision Medicine
The investigator explores targeted therapy approaches with a focus on BRAF genomic alterations across various tumor types. Their work involves molecular-guided treatment selection and personalized medicine strategies.
- Molecular Testing
- Targeted Therapeutics
- Biomarker-Driven Treatment
Their research includes evaluation of targeted agents in diverse cancer types based on specific genetic alterations.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.